Monitoring and evaluation of the health-for-all strategy: experience in the Eastern Mediterranean region

This article is an account of the activities undertaken by the WHO Regional Office for the Eastern Mediterranean in relation to reporting on monitoring and evaluation of progress in the implementation of the strategy for health for all by the year 2000, and the resulting effect on improving coverage and the quality of data. Tables 1-3 compare the completeness of items in the Eastern Mediterranean Region's reports on the three cycles (1983, 1985 and 1988) to that for other regions and for the global level. The comparison is based on the respective global reports presented to the World Health Assembly.     

Survival after gastric adenocarcinoma resection: Eighteen-year experience at a single institution

Gastric adenocarcinoma is the second leading cause of cancer death worldwide. In Western series, survival rates vary widely and are generally lower than those reported from Eastern series. We performed a retrospective analysis of cases operated on at the Johns Hopkins Hospital over the past 18 years and collected data on demographics, tumor characteristics, pathologic stage, treatment methods, complications, survival time, and other relevant factors. Survival according to stage of disease, Lauren tumor type, tumorlocation,time period, andadministration of adjuvant therapy wasanalyzed, andresultswerecompared with those of other Western series. During this period, 436 patients with gastric adenocarcinoma underwent resection. We have shown a statistically significant association between survival and margin status, stage of disease, and Lauren tumor type. Overall 5-year survival was 26%, and 5-year survival after R0 resection was 33%. No significant difference was detected between survival and tumor location, time period of treatment, or administration of adjuvant therapy. Analysis of various Western series reveals major differences between the cohorts under study, such as stage of disease, extent of resection, tumor type, and tumor location. Many of the reported differences among Western series may be due to cohort differences, such as stage of disease, extent of resection, tumor type, and tumor location.